学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
PHASE-II STUDY OF THE ANTIFOLATE N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID (CB-3717) IN ADVANCED BREAST-CANCER
被引:53
作者
:
CANTWELL, BMJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEWCASTLE UPON TYNE, NEWCASTLE GEN HOSP,CTR REG RADIOTHERAPY, DEPT CLIN ONCOL,WESTGATE RD, NEWCASTLE UPON TYNE NE4 6BE, ENGLAND
CANTWELL, BMJ
MACAULAY, V
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEWCASTLE UPON TYNE, NEWCASTLE GEN HOSP,CTR REG RADIOTHERAPY, DEPT CLIN ONCOL,WESTGATE RD, NEWCASTLE UPON TYNE NE4 6BE, ENGLAND
MACAULAY, V
HARRIS, AL
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEWCASTLE UPON TYNE, NEWCASTLE GEN HOSP,CTR REG RADIOTHERAPY, DEPT CLIN ONCOL,WESTGATE RD, NEWCASTLE UPON TYNE NE4 6BE, ENGLAND
HARRIS, AL
KAYE, SB
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEWCASTLE UPON TYNE, NEWCASTLE GEN HOSP,CTR REG RADIOTHERAPY, DEPT CLIN ONCOL,WESTGATE RD, NEWCASTLE UPON TYNE NE4 6BE, ENGLAND
KAYE, SB
SMITH, IE
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEWCASTLE UPON TYNE, NEWCASTLE GEN HOSP,CTR REG RADIOTHERAPY, DEPT CLIN ONCOL,WESTGATE RD, NEWCASTLE UPON TYNE NE4 6BE, ENGLAND
SMITH, IE
MILSTED, RAV
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEWCASTLE UPON TYNE, NEWCASTLE GEN HOSP,CTR REG RADIOTHERAPY, DEPT CLIN ONCOL,WESTGATE RD, NEWCASTLE UPON TYNE NE4 6BE, ENGLAND
MILSTED, RAV
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEWCASTLE UPON TYNE, NEWCASTLE GEN HOSP,CTR REG RADIOTHERAPY, DEPT CLIN ONCOL,WESTGATE RD, NEWCASTLE UPON TYNE NE4 6BE, ENGLAND
CALVERT, AH
机构
:
[1]
UNIV NEWCASTLE UPON TYNE, NEWCASTLE GEN HOSP,CTR REG RADIOTHERAPY, DEPT CLIN ONCOL,WESTGATE RD, NEWCASTLE UPON TYNE NE4 6BE, ENGLAND
[2]
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
[3]
UNIV GLASGOW, DEPT MED ONCOL, GLASGOW G12 8QQ, SCOTLAND
来源
:
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY
|
1988年
/ 24卷
/ 04期
关键词
:
D O I
:
10.1016/0277-5379(88)90307-0
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:733 / 736
页数:4
相关论文
共 6 条
[1]
A PHASE-I EVALUATION OF THE QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR, N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID, CB3717
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
CALVERT, AH
ALISON, DL
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
ALISON, DL
HARLAND, SJ
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
HARLAND, SJ
ROBINSON, BA
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
ROBINSON, BA
JACKMAN, AL
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
JACKMAN, AL
JONES, TR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
JONES, TR
NEWELL, DR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
NEWELL, DR
SIDDIK, ZH
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
SIDDIK, ZH
WILTSHAW, E
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
WILTSHAW, E
MCELWAIN, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
MCELWAIN, TJ
SMITH, IE
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
SMITH, IE
HARRAP, KR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
HARRAP, KR
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1986,
4
(08)
: 1245
-
1252
[2]
CANTWELL BMJ, 1986, CANCER TREAT REP, V70, P1335
[3]
DIDDENS H, 1983, CANCER RES, V43, P5286
[4]
A POTENT ANTI-TUMOR QUINAZOLINE INHIBITOR OF THYMIDYLATE SYNTHETASE - SYNTHESIS, BIOLOGICAL PROPERTIES AND THERAPEUTIC RESULTS IN MICE
JONES, TR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
JONES, TR
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
CALVERT, AH
JACKMAN, AL
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
JACKMAN, AL
BROWN, SJ
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
BROWN, SJ
JONES, M
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
JONES, M
HARRAP, KR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
HARRAP, KR
[J].
EUROPEAN JOURNAL OF CANCER,
1981,
17
(01)
: 11
-
19
[5]
NEWELL DR, 1986, CANCER TREAT REP, V70, P971
[6]
1979, WHO OFFSET PUBLICATI, V48
←
1
→
共 6 条
[1]
A PHASE-I EVALUATION OF THE QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR, N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID, CB3717
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
CALVERT, AH
ALISON, DL
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
ALISON, DL
HARLAND, SJ
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
HARLAND, SJ
ROBINSON, BA
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
ROBINSON, BA
JACKMAN, AL
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
JACKMAN, AL
JONES, TR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
JONES, TR
NEWELL, DR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
NEWELL, DR
SIDDIK, ZH
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
SIDDIK, ZH
WILTSHAW, E
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
WILTSHAW, E
MCELWAIN, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
MCELWAIN, TJ
SMITH, IE
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
SMITH, IE
HARRAP, KR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
HARRAP, KR
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1986,
4
(08)
: 1245
-
1252
[2]
CANTWELL BMJ, 1986, CANCER TREAT REP, V70, P1335
[3]
DIDDENS H, 1983, CANCER RES, V43, P5286
[4]
A POTENT ANTI-TUMOR QUINAZOLINE INHIBITOR OF THYMIDYLATE SYNTHETASE - SYNTHESIS, BIOLOGICAL PROPERTIES AND THERAPEUTIC RESULTS IN MICE
JONES, TR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
JONES, TR
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
CALVERT, AH
JACKMAN, AL
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
JACKMAN, AL
BROWN, SJ
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
BROWN, SJ
JONES, M
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
JONES, M
HARRAP, KR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
HARRAP, KR
[J].
EUROPEAN JOURNAL OF CANCER,
1981,
17
(01)
: 11
-
19
[5]
NEWELL DR, 1986, CANCER TREAT REP, V70, P971
[6]
1979, WHO OFFSET PUBLICATI, V48
←
1
→